ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
DAYBUE Q1 net sales US$75.9m, full-year guidance US$370-420m
Published: 09/05/24, 10:09am (AEST)•25 pages